Michelle M. Lilly
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 0.5%
- Oncology top 2%
- Hematology top 1%
- Immunology top 5%
- Co-authors
- Andrew S. KraftMarina ZemskovaPäivi J. KoskinenJouko SandholmSheldon L. HolderKatriina PeltolaHarri MankonenMatthew R. Janes
- Topics
- Prostate Cancer Treatment and Research (29 papers)Cancer Mechanisms and Therapy (17 papers)Cancer Genomics and Diagnostics (16 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Michelle M. Lilly
100 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 128
- Molecular Biology 2.4k
- Pathology and Forensic Medicine 1.4k
- Oncology 1.3k
- Hematology 653
- Immunology 600
Countries citing papers authored by Michelle M. Lilly
This map shows the geographic impact of Michelle M. Lilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle M. Lilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle M. Lilly more than expected).
Fields of papers citing papers by Michelle M. Lilly
This network shows the impact of papers produced by Michelle M. Lilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle M. Lilly. The network helps show where Michelle M. Lilly may publish in the future.
Co-authorship network of co-authors of Michelle M. Lilly
This figure shows the co-authorship network connecting the top 25 collaborators of Michelle M. Lilly. A scholar is included among the top collaborators of Michelle M. Lilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle M. Lilly. Michelle M. Lilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 5 | |
| 5 | 91 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 41 | |
| 9 | 51 | |
| 10 | 5 | |
| 11 | 26 | |
| 12 | 34 | |
| 13 | 83 | |
| 14 | 108 | |
| 15 | 101 | |
| 16 | 110 | |
| 17 | 158 | |
| 18 | 276 | |
| 19 | 17 | |
| 20 | Loss of high-energy phosphate following hyperthermia demonstrated by in vivo 31P-nuclear magnetic resonance spectroscopy. | 61 |
About Michelle M. Lilly
Michelle M. Lilly is a scholar working on Cancer Research, Oncology and Hematology, having authored 103 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (29 papers), Cancer Mechanisms and Therapy (17 papers) and Cancer Genomics and Diagnostics (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Hematology (653 citations) and Oncology (1.3k citations). Michelle M. Lilly has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Andrew S. Kraft, Marina Zemskova, Päivi J. Koskinen, Jouko Sandholm, Sheldon L. Holder, Katriina Peltola, Harri Mankonen, Matthew R. Janes, I Brezovich and Eva Sahakian. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.